Kardigan
Healthcare & Life Sci
Company overview
Kardigan is a clinical-stage precision therapeutics company based in South San Francisco. It develops AI-driven medicines for cardiovascular diseases, including cardiomyopathies. Its portfolio targets the underlying pathophysiology of cardiovascular disease, using artificial intelligence, real-world clinical data, and cardiac-specific analytics.
Kardigan was founded in 2023 as EnCarda, based in Princeton, New Jersey. It rebranded as Kardigan in December 2024. As a clinical-stage company, it is still developing its medicines rather than selling them yet. Kardigan is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- South San Francisco, United States